Long-term results of high-dose imatinib in children and adolescents with chronic myeloid leukaemia in chronic phase: the Italian experience.
about
Pediatric chronic myeloid leukemia is a unique disease that requires a different approachDasatinib in Pediatric Patients With Chronic Myeloid Leukemia in Chronic Phase: Results From a Phase II Trial.Early response does not predict outcome in children and adolescents with chronic myeloid leukaemia treated with high-dose imatinib.
P2860
Long-term results of high-dose imatinib in children and adolescents with chronic myeloid leukaemia in chronic phase: the Italian experience.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Long-term results of high-dose ...... phase: the Italian experience.
@en
Long-term results of high-dose ...... phase: the Italian experience.
@nl
type
label
Long-term results of high-dose ...... phase: the Italian experience.
@en
Long-term results of high-dose ...... phase: the Italian experience.
@nl
prefLabel
Long-term results of high-dose ...... phase: the Italian experience.
@en
Long-term results of high-dose ...... phase: the Italian experience.
@nl
P2093
P2860
P50
P921
P356
P1476
Long-term results of high-dose ...... phase: the Italian experience.
@en
P2093
Alfonso Piciocchi
Andrea Biondi
Caterina Consarino
Chiara Messina
Concetta Micalizzi
Daniela Diverio
Enrico Gottardi
Fiorina Giona
Francesca Tucci
Giuseppe Menna
P2860
P304
P356
10.1111/BJH.13453
P407
P577
2015-04-20T00:00:00Z